Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)

Background: Hepatitis B is endemic in Indonesia and treatment response need to be monitored during and after antiviral therapy. Liver stiffness measurement and alanine aminotransferase-to-platelet ratio index (APRI) are noninvasive method to detect liver fibrosis available in Indonesia. However, lit...

Full description

Bibliographic Details
Main Authors: Ignatius R Tenggara, C Rinaldi Lesmana, Rino A Gani
Format: Article
Language:English
Published: Interna Publishing 2017-11-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:http://actamedindones.org/index.php/ijim/article/view/195
id doaj-da088cf5ba45439eb31943024eb68cf0
record_format Article
spelling doaj-da088cf5ba45439eb31943024eb68cf02020-11-25T00:52:18ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322017-11-01493218Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)Ignatius R Tenggara0C Rinaldi Lesmana1Rino A Gani2Department of Internal Medicine, Atma Jaya University, Jakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaBackground: Hepatitis B is endemic in Indonesia and treatment response need to be monitored during and after antiviral therapy. Liver stiffness measurement and alanine aminotransferase-to-platelet ratio index (APRI) are noninvasive method to detect liver fibrosis available in Indonesia. However, little is known about their ability to evaluate treatment response in chronic hepatitis B (CHB) patients in Indonesia. This study aimed to investigate liver stiffness changes by transient elastography (TE) and APRI before and after one-year oral antiviral treatment in CHB patients and the correlation between TE and APRI. Methods: this study was retrospective cohort on CHB patients in CiptoMangunkusumo Hospital, Jakarta who uderwent treatment between January 2012 and December 2014. Patients received oral antiviral treatment with newer nucleoside analogues (entecavir or telbivudine) for at least one year. TE and APRI were obtained before and after treatment. TE and APRI reductions were analyzed statistically with Spearman’s test. Results: a total of 41 patients were enrolled in this study. Median liver stiffness value was significantly reduced from 10.8 to 5.9 kPa after oral antiviral treatment (p<0.001, Wilcoxon’s test). Median APRI was also significantly reduced from 1.13 to 0.43 after treatment (p<0.001, Wilcoxon’s test). The correlation between liver stiffness and APRI before treatment was weak (r=0.40), but it was strong after treatment (r=0.73). Conclusion: the liver stiffness measured with transient elastography and APRI significantly decreased after one year of antiviral treatment in chronic HBV patients. There was a significant correlation between TE and APRI after one year of treatment.http://actamedindones.org/index.php/ijim/article/view/195antiviral therapyaspartate aminotransferase-to-platelet ratio index (APRI)chronic hepatitis Bliver stiffness measurementtransient elastography
collection DOAJ
language English
format Article
sources DOAJ
author Ignatius R Tenggara
C Rinaldi Lesmana
Rino A Gani
spellingShingle Ignatius R Tenggara
C Rinaldi Lesmana
Rino A Gani
Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
Acta Medica Indonesiana
antiviral therapy
aspartate aminotransferase-to-platelet ratio index (APRI)
chronic hepatitis B
liver stiffness measurement
transient elastography
author_facet Ignatius R Tenggara
C Rinaldi Lesmana
Rino A Gani
author_sort Ignatius R Tenggara
title Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
title_short Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
title_full Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
title_fullStr Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
title_full_unstemmed Treatment Response Monitoring of Chronic Hepatitis B Patients using Transient Elastography and Aspartate Aminotransferase-to-Platelet Ratio Index (APRI)
title_sort treatment response monitoring of chronic hepatitis b patients using transient elastography and aspartate aminotransferase-to-platelet ratio index (apri)
publisher Interna Publishing
series Acta Medica Indonesiana
issn 0125-9326
2338-2732
publishDate 2017-11-01
description Background: Hepatitis B is endemic in Indonesia and treatment response need to be monitored during and after antiviral therapy. Liver stiffness measurement and alanine aminotransferase-to-platelet ratio index (APRI) are noninvasive method to detect liver fibrosis available in Indonesia. However, little is known about their ability to evaluate treatment response in chronic hepatitis B (CHB) patients in Indonesia. This study aimed to investigate liver stiffness changes by transient elastography (TE) and APRI before and after one-year oral antiviral treatment in CHB patients and the correlation between TE and APRI. Methods: this study was retrospective cohort on CHB patients in CiptoMangunkusumo Hospital, Jakarta who uderwent treatment between January 2012 and December 2014. Patients received oral antiviral treatment with newer nucleoside analogues (entecavir or telbivudine) for at least one year. TE and APRI were obtained before and after treatment. TE and APRI reductions were analyzed statistically with Spearman’s test. Results: a total of 41 patients were enrolled in this study. Median liver stiffness value was significantly reduced from 10.8 to 5.9 kPa after oral antiviral treatment (p<0.001, Wilcoxon’s test). Median APRI was also significantly reduced from 1.13 to 0.43 after treatment (p<0.001, Wilcoxon’s test). The correlation between liver stiffness and APRI before treatment was weak (r=0.40), but it was strong after treatment (r=0.73). Conclusion: the liver stiffness measured with transient elastography and APRI significantly decreased after one year of antiviral treatment in chronic HBV patients. There was a significant correlation between TE and APRI after one year of treatment.
topic antiviral therapy
aspartate aminotransferase-to-platelet ratio index (APRI)
chronic hepatitis B
liver stiffness measurement
transient elastography
url http://actamedindones.org/index.php/ijim/article/view/195
work_keys_str_mv AT ignatiusrtenggara treatmentresponsemonitoringofchronichepatitisbpatientsusingtransientelastographyandaspartateaminotransferasetoplateletratioindexapri
AT crinaldilesmana treatmentresponsemonitoringofchronichepatitisbpatientsusingtransientelastographyandaspartateaminotransferasetoplateletratioindexapri
AT rinoagani treatmentresponsemonitoringofchronichepatitisbpatientsusingtransientelastographyandaspartateaminotransferasetoplateletratioindexapri
_version_ 1725242978606252032